Literature DB >> 6478673

The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.

A M Davison, J S Cameron, D N Kerr, C S Ogg, R W Wilkinson.   

Abstract

Sixty-four patients (47 male, 17 females) aged between 20 and 70 years with idiopathic membranous glomerulonephritis, never having received steroid or immunosuppressive drugs prior to and subsequent to biopsy, have been followed to terminal renal failure or for a minimum of two up to fifteen years. Presentation was with asymptomatic proteinuria in 12 and nephrotic syndrome in 52. The serum creatinine at time of biopsy was less than or equal to 99 mumoles/l in 25, 100-119 mumoles/l in 18 and greater than or equal to 120 mumoles/l in 21. During the follow up there was no deterioration in renal function in 30 patients (48%). In 27 patients (43.5%) there was a steady deterioration in renal function, on the average 30 months (range 5-60) for the serum creatinine to double and 32 months (range 5-49) for the serum creatinine to reach 400 mumoles/l. In five patients there was a slow deterioration. A plot of the reciprocal of the sequential serum creatinine values with time indicates that the rate of deterioration is essentially constant in any patient but that there is a wide variation between patients. The reciprocal of the serum creatinine is a useful means of following the evolution of the disease. In two patients there was a change in the rate of deterioration and a cause could be identified (one with renal vein thrombosis, one with interstitial nephritis). Poor prognostic indicators were: nephrotic syndrome at presentation, impaired function at time of diagnosis, male patients and older age.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478673

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  33 in total

1.  The solution structure of the N-terminal domain of alpha2-macroglobulin receptor-associated protein.

Authors:  P R Nielsen; L Ellgaard; M Etzerodt; H C Thogersen; F M Poulsen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.

Authors:  L R Baker; B Tucker; I C Macdougall; R Oommen
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

Review 3.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 4.  Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management.

Authors:  Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 5.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

Review 6.  Management of progressive renal failure: the role of dietary manipulations.

Authors:  A M el Nahas
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

7.  Clinical significance of glomerular C3 deposition in primary membranous nephropathy.

Authors:  Halil Yazici; Yasar Caliskan; Ozgur Akin Oto; Erol Demir; Safak Mirioglu; Ahmet Burak Dirim; Yasemin Ozluk; Egemen Cebeci; Taner Basturk; Ali Riza Ucar; Lala Soltanova; Kanan Nuriyev; Isin Kilicaslan
Journal:  J Nephrol       Date:  2021-01-02       Impact factor: 3.902

8.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

9.  Long-term prognosis of chronic glomerulonephritis.

Authors:  S I Ryabov; V V Stavskaya
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

10.  Clinical course and outcome of idiopathic membranous nephropathy in Japanese children.

Authors:  H Tsukahara; Y Takahashi; M Yoshimoto; S Hayashi; S Fujisawa; F Suehiro; K Akaishi; Y Nomura; K Morikawa; M Sudo
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.